5-(bromomethyl)piperidin-2-one
|
P630685-500mg
|
≥97% |
1820608-69-2 |
500mg
|
¥ 2539.9
|
期货,请咨询 |
阿拉丁 |
5-(bromomethyl)piperidin-2-one
|
P630685-250mg
|
≥97% |
1820608-69-2 |
250mg
|
¥ 1813.9
|
期货,请咨询 |
阿拉丁 |
5-(bromomethyl)piperidin-2-one
|
P630685-1g
|
≥97% |
1820608-69-2 |
1g
|
¥ 3628.9
|
期货,请咨询 |
阿拉丁 |
5-(bromomethyl)piperidin-2-one
|
P630685-10g
|
≥97% |
1820608-69-2 |
10g
|
¥ 29040.9
|
期货,请咨询 |
阿拉丁 |
5-(bromomethyl)piperidin-2-one
|
P630685-100mg
|
≥97% |
1820608-69-2 |
100mg
|
¥ 1087.9
|
期货,请咨询 |
阿拉丁 |
(2S)-2-{[(benzyloxy)carbonyl]amino}-3-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}propanoic acid
|
P630683-500mg
|
≥97% |
1820583-71-8 |
500mg
|
¥ 4268.9
|
期货,请咨询 |
阿拉丁 |
(2S)-2-{[(benzyloxy)carbonyl]amino}-3-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}propanoic acid
|
P630683-250mg
|
≥97% |
1820583-71-8 |
250mg
|
¥ 2558.9
|
期货,请咨询 |
阿拉丁 |
(2S)-2-{[(benzyloxy)carbonyl]amino}-3-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}propanoic acid
|
P630683-1g
|
≥97% |
1820583-71-8 |
1g
|
¥ 7682.9
|
期货,请咨询 |
阿拉丁 |
(2S)-2-{[(benzyloxy)carbonyl]amino}-3-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}propanoic acid
|
P630683-100mg
|
≥97% |
1820583-71-8 |
100mg
|
¥ 1601.9
|
期货,请咨询 |
阿拉丁 |
(2R,3S)-2-phenylpyrrolidine-3-carboxylic acid;hydrochloride
|
P630676-500mg
|
≥97% |
1820575-92-5 |
500mg
|
¥ 3397.9
|
期货,请咨询 |
阿拉丁 |
(2R,3S)-2-phenylpyrrolidine-3-carboxylic acid;hydrochloride
|
P630676-250mg
|
≥97% |
1820575-92-5 |
250mg
|
¥ 2057.9
|
期货,请咨询 |
阿拉丁 |
(2R,3S)-2-phenylpyrrolidine-3-carboxylic acid;hydrochloride
|
P630676-1g
|
≥97% |
1820575-92-5 |
1g
|
¥ 6383.9
|
期货,请咨询 |
阿拉丁 |
(2R,3S)-2-phenylpyrrolidine-3-carboxylic acid;hydrochloride
|
P630676-100mg
|
≥97% |
1820575-92-5 |
100mg
|
¥ 1285.9
|
期货,请咨询 |
阿拉丁 |
(3S)-3-(2-methoxyethoxy)pyrrolidine hydrochloride
|
P630650-5g
|
≥97% |
1810074-91-9 |
5g
|
¥ 1510.9
|
期货,请咨询 |
阿拉丁 |
(3S)-3-(2-methoxyethoxy)pyrrolidine hydrochloride
|
P630650-1g
|
≥97% |
1810074-91-9 |
1g
|
¥ 380.9
|
期货,请咨询 |
阿拉丁 |
(3S)-3-(2-methoxyethoxy)pyrrolidine hydrochloride
|
P630650-10g
|
≥97% |
1810074-91-9 |
10g
|
¥ 3020.9
|
期货,请咨询 |
阿拉丁 |
(3R,4R)-1-[(tert-butoxy)carbonyl]-4-(trifluoromethyl)pyrrolidine-3-carboxylic acid
|
P630637-500mg
|
≥97% |
1808807-76-2 |
500mg
|
¥ 5548.9
|
期货,请咨询 |
阿拉丁 |
(3R,4R)-1-[(tert-butoxy)carbonyl]-4-(trifluoromethyl)pyrrolidine-3-carboxylic acid
|
P630637-250mg
|
≥97% |
1808807-76-2 |
250mg
|
¥ 3331.9
|
期货,请咨询 |
阿拉丁 |
(3R,4R)-1-[(tert-butoxy)carbonyl]-4-(trifluoromethyl)pyrrolidine-3-carboxylic acid
|
P630637-1g
|
≥97% |
1808807-76-2 |
1g
|
¥ 9987.9
|
期货,请咨询 |
阿拉丁 |
(3R,4R)-1-[(tert-butoxy)carbonyl]-4-(trifluoromethyl)pyrrolidine-3-carboxylic acid
|
P630637-100mg
|
≥97% |
1808807-76-2 |
100mg
|
¥ 2083.9
|
期货,请咨询 |
阿拉丁 |
pyrrolo[1,2-b]pyridazine-3-carbonitrile
|
P630547-5g
|
≥97% |
1803184-79-3 |
5g
|
¥ 24784.9
|
期货,请咨询 |
阿拉丁 |
pyrrolo[1,2-b]pyridazine-3-carbonitrile
|
P630547-500mg
|
≥97% |
1803184-79-3 |
500mg
|
¥ 3265.9
|
期货,请咨询 |
阿拉丁 |
pyrrolo[1,2-b]pyridazine-3-carbonitrile
|
P630547-250mg
|
≥97% |
1803184-79-3 |
250mg
|
¥ 1978.9
|
期货,请咨询 |
阿拉丁 |
pyrrolo[1,2-b]pyridazine-3-carbonitrile
|
P630547-1g
|
≥97% |
1803184-79-3 |
1g
|
¥ 5217.9
|
期货,请咨询 |
阿拉丁 |